Defining the Eye–Skin Axis
Modern ophthalmology continues to evolve, constantly seeking new ways to understand and care for the ocular surface. In recent years, it has become increasingly clear that the eye cannot be approached in isolation, but rather as part of a broader, integrated biological system.
Dermophthalmology® emerges precisely to address this scientific gap, focusing on the Eye–Skin Axis and, more specifically, on the functional and biological continuity between the eyelids, the skin, and the ocular surface.
The eyelid is not merely an anatomical “boundary,” but a dynamic regulator of ocular health. Skin condition, eyelash quality, and the function of the eyelid glands directly influence tear film stability, visual comfort, and ultimately the patient’s quality of life.
What’s above defines what’s below.
Within this scientific framework, Ophthalmogen participates in this year’s Panhellenic Ophthalmology Congress of OMMA, presenting the concept of Dermophthalmology and the Eye–Skin Axis in a clear and institutional manner. This presence is not intended as product promotion, but rather as a statement of scientific direction and the introduction of a new field that bridges Ophthalmology and Dermatology.
Dermophthalmology, conceived in Greece, represents a contemporary scientific proposition with international perspective, grounded in a deeper understanding of the unified eye–skin surface. Through this philosophy, Ophthalmogen positions itself globally as the first brand to recognize, define, and systematically serve this axis.
The presence at the Panhellenic Ophthalmology Congress of OMMA marks another step toward shaping a new way of thinking in ocular care — one that does not divide, but unifies.
